HRT Financial’s Nektar Therapeutics NKTR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-4,545
| Closed | -$46K | – | 2943 |
|
|
2025
Q1 | $46K | Buy |
+4,545
| New | +$46K | ﹤0.01% | 2015 |
|
|
2024
Q1 | – | Sell |
-4,700
| Closed | -$39K | – | 2665 |
|
|
2023
Q4 | $39K | Buy |
4,700
+2,422
| +106% | +$20.1K | ﹤0.01% | 1813 |
|
|
2023
Q3 | $20K | Sell |
2,278
-13,339
| -85% | -$117K | ﹤0.01% | 1852 |
|
|
2023
Q2 | $134K | Sell |
15,617
-9,657
| -38% | -$82.9K | ﹤0.01% | 1739 |
|
|
2023
Q1 | $266K | Sell |
25,274
-2,756
| -10% | -$29K | ﹤0.01% | 1632 |
|
|
2022
Q4 | $950K | Buy |
28,030
+12,510
| +81% | +$424K | 0.01% | 942 |
|
|
2022
Q3 | $744K | Buy |
15,520
+7,956
| +105% | +$381K | 0.01% | 1069 |
|
|
2022
Q2 | $431K | Sell |
7,564
-15,097
| -67% | -$860K | ﹤0.01% | 1731 |
|
|
2022
Q1 | $1.83M | Buy |
+22,661
| New | +$1.83M | 0.01% | 611 |
|
|
2021
Q4 | – | Sell |
-2,098
| Closed | -$565K | – | 3458 |
|
|
2021
Q3 | $565K | Buy |
2,098
+52
| +3% | +$14K | ﹤0.01% | 1685 |
|
|
2021
Q2 | $526K | Buy |
2,046
+463
| +29% | +$119K | ﹤0.01% | 1643 |
|
|
2021
Q1 | $474K | Buy |
+1,583
| New | +$474K | ﹤0.01% | 1655 |
|
|
2020
Q4 | – | Sell |
-1,095
| Closed | -$272K | – | 2175 |
|
|
2020
Q3 | $272K | Sell |
1,095
-90
| -8% | -$22.4K | 0.01% | 1127 |
|
|
2020
Q2 | $411K | Buy |
+1,185
| New | +$411K | 0.01% | 765 |
|
|
2020
Q1 | – | Sell |
-760
| Closed | -$246K | – | 1050 |
|
|
2019
Q4 | $246K | Sell |
760
-182
| -19% | -$58.9K | 0.01% | 798 |
|
|
2019
Q3 | $257K | Buy |
+942
| New | +$257K | 0.01% | 912 |
|
|
2018
Q3 | – | Sell |
-575
| Closed | -$421K | – | 421 |
|
|
2018
Q2 | $421K | Buy |
+575
| New | +$421K | 0.15% | 116 |
|